ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2025

Aug 20, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2025-08-18

Reporting Person: Shah Gaurav (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-18	Common Stock	F	2234	$3.05	Disposed	784572	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	207897	Indirect
Common Stock	198341	Indirect

Footnotes

F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.

F2: The shares of common stock were withheld by the Company in order to pay tax withholding obligations in connection with the vesting of RSUs.